Ligand Pharmaceuticals

(NASDAQ) LGND

Current Price$221.59

Market Cap$4.44B

Since IPO (1994)+663%

5 Year+178%

1 Year+116%

1 Month+6%

Ligand Pharmaceuticals Financials at a Glance

Market Cap

$4.44B

Revenue (TTM)

$274.48M

Net Income (TTM)

$153.56M

EPS (TTM)

$7.38

P/E Ratio

30.02

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$221.59

Volume

73,769.793

Open

$221.41

Price

$221.59

Volume

73,769.793

Open

$221.41

Previous Close

$221.41

Daily Range

$218.00 - $225.81

52-Week Range

$98.89 - $247.38

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$221.59

Volume

73,769.793

Open

$221.41

Previous Close

$221.41

Daily Range

$218.00 - $225.81

52-Week Range

$98.89 - $247.38

LGND News

CLO Sells LGND 5,000 Shares for $1.0 Million

Seena HassounaMar 30, 2026

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know

Jonathan PoncianoMar 27, 2026

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know

Jonathan PoncianoNov 17, 2025

Page 1

LGND: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ligand Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Todd Christopher Davis, MBA

Website

www.ligand.com

Headquarters

Jupiter, CA 94608, US

LGND Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

37%

Net Income Margin

56%

Return on Equity

17%

Return on Capital

Return on Assets

10%

Earnings Yield

3.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.44B

Shares Outstanding

20.04M

Volume

73.77K

Avg. Volume

227.38K

Financials (TTM)

Gross Profit

$261.50M

Operating Income

$47.20M

EBITDA

$192.74M

Operating Cash Flow

$49.36M

Capital Expenditure

$452.00K

Free Cash Flow

$48.91M

Cash & ST Invst.

$733.52M

Total Debt

$451.49M

Ligand Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$51.72M

+14.1%

Gross Profit

$49.65M

+22.6%

Gross Margin

95.99%

N/A

Market Cap

$4.44B

N/A

Market Cap/Employee

$65.25M

N/A

Employees

N/A

Net Income

$13.35M

+68.6%

EBITDA

$17.37M

+142.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$327.43M

+60.1%

Accounts Receivable

$54.80M

+27.9%

Inventory

$13.27M

+12.3%

Long Term Debt

$450.89M

+12547.7%

Short Term Debt

$1.09M

+23.2%

Return on Assets

10.02%

N/A

Return on Invested Capital

6.76%

N/A

Free Cash Flow

$48.46M

+288.4%

Operating Cash Flow

$48.69M

+290.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NAMSNewAmsterdam Pharma Company N.V.

NAMSNewAmsterdam Pharma Company N.V.$40.36+4.20%

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$36.45-2.76%

ACADACADIA Pharmaceuticals Inc.

ACADACADIA Pharmaceuticals Inc.$22.07-1.50%

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$31.60+0.86%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$105.66-1.40%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$18.17+3.17%

BLTEBelite Bio, Inc

BLTEBelite Bio, Inc$152.77-1.36%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.37+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.89+0.01%

ODYSOdysight.ai

ODYSOdysight.ai$5.46+0.22%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.23-0.01%

DGXXDigi Power X

DGXXDigi Power X$7.73+0.17%

CRCLCircle Internet Group

CRCLCircle Internet Group$128.37+0.13%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$7.08-0.05%

Questions About LGND

What is the current price of Ligand Pharmaceuticals?

Ligand Pharmaceuticals is trading at $221.60 per share.

What is the 52-week range for Ligand Pharmaceuticals?

Over the past 52 weeks, Ligand Pharmaceuticals has traded between $98.89 and $247.38.

How much debt does Ligand Pharmaceuticals have?

As of the most recent reporting period, Ligand Pharmaceuticals reported total debt of $451.98M.

How much cash does Ligand Pharmaceuticals have on hand?

Ligand Pharmaceuticals reported $115.09M in cash and cash equivalents in its most recent financial results.

What is Ligand Pharmaceuticals’s dividend yield?

Ligand Pharmaceuticals does not currently have a dividend yield.

Ligand Pharmaceuticals

Ligand Pharmaceuticals Financials at a Glance

LGND News

CLO Sells LGND 5,000 Shares for $1.0 Million

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know

Ligand (LGND) Q2 Revenue Jumps 15%

Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug

3 Signs the Ligand Short Squeeze Is Over

Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now

Short-Sellers Have These 3 ETFs in Their Sights

LGND: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ligand Pharmaceuticals

LGND Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ligand Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LGND

What is the current price of Ligand Pharmaceuticals?

What is the 52-week range for Ligand Pharmaceuticals?

How much debt does Ligand Pharmaceuticals have?

How much cash does Ligand Pharmaceuticals have on hand?

What is Ligand Pharmaceuticals’s dividend yield?

Premium Investing Services